MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients-Reference-Cited by-同舟云学术

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

Published:2015-10-07 Issue:35 Volume:6 Page:37269-37280
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

De Mattos-Arruda Leticia¹,Bottai Giulia²,Nuciforo Paolo G.³,Di Tommaso Luca⁴,Giovannetti Elisa⁵⁶,Peg Vicente⁷,Losurdo Agnese⁸,Pérez-Garcia José¹,Masci Giovanna⁸,Corsi Fabio⁹,Cortés Javier¹¹⁰,Seoane Joan¹¹¹,Calin George A.¹²¹³,Santarpia Libero²

Affiliation:

1. Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

2. Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy

3. Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain

4. Division of Pathology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy, University of Milan, Milan, Italy

5. Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

6. Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy

7. Pathology Department, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain

8. Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy

9. Deparment of Clinical and Biomedical Sciences “Luigi Sacco”, University of Milan, Milan, Italy

10. Ramon y Cajal University Hospital, Madrid, Spain

11. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

12. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

13. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review;Biochemistry and Biophysics Reports;2024-03

2. Non-coding RNAs mediated inflammation in breast cancers;Seminars in Cell & Developmental Biology;2024-02

3. miRNAs as biomarkers breast cancer and their influence on tumor epigenetics;Epigenetics in Human Disease;2024

4. Inflammatory cytokines and two subtypes of breast cancer: A two-sample mendelian randomization study;PLOS ONE;2023-11-01

5. Exosomal miRNAs as Next-generation Therapy Vehicles in Breast Cancer;Current Gene Therapy;2023-10